IRVINE, Calif., July 15 Edwards LifesciencesCorporation (NYSE: EW), a world leader in products and technologies to treatadvanced cardiovascular disease, plans to announce its operating results forthe quarter ended June 30, 2008 after the market closes on Tuesday, July 22,2008 and will host a conference call at 5:00 p.m. ET that day to discuss itsresults.
To participate in the conference call, dial (877) 407-8037 or(201) 689-8037. For 72 hours following the call, an audio replay can beaccessed by dialing (877) 660-6853 or (201) 612-7415 and using account number2995 and conference number 288895. The call will also be available via liveor archived webcast on the "Investor Relations" section of the Edwards website at http://www.edwards.com orhttp://www.edwards.com/InvestorRelations/EventCalendar.htm.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valvesand hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards treatsadvanced cardiovascular disease with its market-leading heart valve therapies,and critical care and vascular technologies. In 2008, Edwards celebrates 50years of partnering with clinicians to develop life-saving innovations. Thecompany's global brands, which are sold in approximately 100 countries,include CardioVations, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty,PERIMOUNT Magna and Swan-Ganz. Additional company information can be found athttp://www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation. EdwardsLifesciences, the stylized E logo, CardioVations, Carpentier-Edwards,Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT, PERIMOUNT Magna and Swan-Ganzare trademarks of Edwards Lifesciences Corporation and are registered in theUnited States Patent and Trademark Office.
SOURCE Edwards Lifesciences Corporation